Academic Publications - Selected

1. A Saini and JM Gallo. Epigenetic Instability May Alter Cell State Transitions and Anticancer Drug Resistance.

PLoS Comput Biol​, 17(8):e1009307, 2021 Aug 23. Online ahead of Print.

2. JM Gallo. Hybrid Physiologically-Based Pharmacokinetic Model for Remdesivir: Application SARS-CoV-2. Clin Transl Sci Online ahead of print Jan 6 2021, DOI: 10.1111/cts.12975., PMID: 33404204

3. R Iyengar, S Zhao, S-W Chung, DE Mager and JM Gallo. Merging systems biology with pharmacodynamics. Science Trans Med, 4:126ps7, 2012. PMCID: PMC3405973.

4. MR. Birtwistle, DE Mager, JM Gallo. Mechanistic Versus Empirical Network Models of Drug Action. CPT:Pharmacometrics Syst Pharmacol 2: e72, 2013. PMCID: PMC4026635.

5. X Zhang, MR Birtwistle, JM Gallo. A General Network Pharmacodynamic Model-Based Design Pipeline for Customized Cancer Chemotherapy. CPT:Pharmacometrics and Syst Pharmacol 3:e92, 2013. PMCID: PMC3910016.

6. JM Gallo. Modulation of Cell State to Improve Drug Therapy. CPT:Pharmacometrics Syst Pharmacol, 7:539-542, 2018. PMCID: PMC6157657.

7. J Sharma, H Lv and JM Gallo. Intratumoral Pharmacokinetic and Pharmacodynamic Modeling of Gefitinib in a Mouse Orthotopic Glioblastoma Model. Cancer Res, 73:5242-52, 2013.PMCID: PMC3755354.

8.  A Ballesta, Q Zhou, X Zhang, H Lv, and JM Gallo. A multi-scale approach to develop cell type-specific pharmacokinetic/pharmacodynamic models:  intracellular brain and brain tumor disposition of temozolomide. CPT:Pharmacometrics Syst Pharmacol, 3, e112,2014. PMCID: PMC4017092.